# Trade Mark Journal No.2025/041 10 October 2025

## WO0000001877039 (5)

Office of origin: United States of America

Date of International Registration:19 August 2025
Date of designation in the UK: 19 August 2025

International priority date claimed: 26 February 2025 (United States of America) (99057610)

Class 5
  Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis and monitoring of cancer.

Progenics Pharmaceuticals, Inc.

Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA